Quest Diagnostics Announces Quarterly Dividend
Quest Diagnostics (NYSE: DGX), a prominent name in diagnostic information services, has recently made an important announcement regarding its financial dividends. The company has declared a cash dividend of $0.80 per share. This dividend will enhance shareholder value and reflects Quest's commitment to its investors.
Details of the Dividend Payment
The Board of Directors has confirmed that this quarterly dividend is set to be paid on January 28, 2026. Shareholders with common stock of Quest Diagnostics will receive this dividend if they are on record by January 13, 2026. This strategic decision reinforces the company’s strong financial position and focus on providing consistent returns to its shareholders.
About Quest Diagnostics
Leading Healthcare Solutions Provider
Quest Diagnostics is dedicated to enhancing health across the globe. By delivering essential diagnostic insights from lab testing, the company empowers individuals, healthcare professionals, and organizations to take proactive steps towards improving health outcomes. With access to one of the largest clinical lab result databases, Quest Diagnostics offers groundbreaking insights into disease identification and treatment.
Impact on Public Health
Quest serves a substantial portion of the U.S. populace—annually assisting one in three adult Americans. Furthermore, it collaborates with nearly half of all physicians and hospitals nationwide. This outreach illustrates the immense impact Quest has on public health management.
Commitment to Actionable Insights
With over 55,000 employees, Quest Diagnostics strives to leverage its diagnostic insights to effect transformative healthcare actions. They understand the importance of context when interpreting diagnostic results and how these insights can inspire actions that lead to healthier lives.
Future Outlook
As Quest Diagnostics continues to innovate and adapt in the healthcare landscape, investors can look forward to ongoing updates regarding future dividends and advancements in diagnostic services. The company’s proactive approach positions it well for future growth and an ever-increasing contribution to global health.
Frequently Asked Questions
What is the announced dividend amount for Quest Diagnostics?
Quest Diagnostics has declared a quarterly cash dividend of $0.80 per share.
When will the dividend be paid?
The dividend is scheduled to be paid on January 28, 2026.
Who qualifies for the dividend payment?
Shareholders of record for Quest Diagnostics common stock as of January 13, 2026, will qualify for the dividend payment.
How does Quest Diagnostics impact healthcare?
Quest Diagnostics enhances public health by providing critical diagnostic insights, enabling informed actions to improve health outcomes.
What is the mission of Quest Diagnostics?
Quest Diagnostics aims to create a healthier world through diagnostic insights that empower individuals and healthcare organizations.
